BioRestorative Therapies, Inc. financial data

Symbol
BRTX on Nasdaq
Location
40 Marcus Drive, Melville, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 257 % -33.7%
Debt-to-equity 54.8 % +75.2%
Return On Equity -145 % -342%
Return On Assets -93.9 % -275%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.98M shares +17.8%
Common Stock, Shares, Outstanding 7.98M shares +15.3%
Entity Public Float 11.5M USD -16.1%
Common Stock, Value, Issued 797 USD +15.2%
Weighted Average Number of Shares Outstanding, Basic 8.74M shares +7.62%
Weighted Average Number of Shares Outstanding, Diluted 8.74M shares +7.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 605K USD +248%
Research and Development Expense 6.78M USD +53.6%
General and Administrative Expense 6.89M USD -20.5%
Operating Income (Loss) -13.1M USD -1.45%
Nonoperating Income (Expense) 2.37M USD -74%
Net Income (Loss) Attributable to Parent -10.7M USD -183%
Earnings Per Share, Basic -1 USD/shares -1370%
Earnings Per Share, Diluted -1 USD/shares -1370%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.56M USD -30.9%
Marketable Securities, Current 5.83M USD -53.1%
Accounts Receivable, after Allowance for Credit Loss, Current 15K USD -45.3%
Assets, Current 7.6M USD -49.4%
Property, Plant and Equipment, Net 340K USD -1.77%
Operating Lease, Right-of-Use Asset 39.7K USD -74.3%
Intangible Assets, Net (Excluding Goodwill) 579K USD -13.4%
Assets 8.52M USD -47.2%
Accounts Payable, Current 610K USD +182%
Employee-related Liabilities, Current 359K USD
Accrued Liabilities, Current 744K USD +4.61%
Contract with Customer, Liability, Current 150K USD
Liabilities, Current 3.67M USD -31%
Operating Lease, Liability, Noncurrent 42.4K USD -78.7%
Liabilities 3.67M USD -31%
Retained Earnings (Accumulated Deficit) -164M USD -7.01%
Stockholders' Equity Attributable to Parent 4.85M USD -55.1%
Liabilities and Equity 8.52M USD -47.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.78M USD -19.9%
Net Cash Provided by (Used in) Financing Activities 1.09M USD -85.5%
Net Cash Provided by (Used in) Investing Activities 2.37M USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 7.98M shares +15.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 681K USD +150%
Deferred Tax Assets, Valuation Allowance 29.4M USD -7.56%
Deferred Tax Assets, Gross 29.7M USD -7.5%
Operating Lease, Liability 42.4K USD -78.7%
Payments to Acquire Property, Plant, and Equipment 36.4K USD
Lessee, Operating Lease, Liability, to be Paid 43.3K USD -79.9%
Property, Plant and Equipment, Gross 1.47M USD +7.76%
Operating Lease, Liability, Current 42.4K USD -72.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 173K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 851 USD -94.8%
Deferred Tax Assets, Operating Loss Carryforwards 18M USD +25.8%
Preferred Stock, Shares Authorized 20M shares 0%
Operating Lease, Payments 43.3K USD +3%
Additional Paid in Capital 169M USD +2.91%
Amortization of Intangible Assets 22.4K USD +20.4%
Depreciation, Depletion and Amortization 39.4K USD +51.3%
Share-based Payment Arrangement, Expense 2.94M USD -44.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%